Koers MDxHealth SA Euronext Bruxelles
Aandelen
MDXH
BE0974461940
Biotechnologie & Medisch Onderzoek
Omzet 2023 | 64,39 mln. 69,48 mln. | Omzet 2024 * | 73,13 mln. 78,91 mln. | Marktkapitalisatie | 62,15 mln. 67,06 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -39 mln. -42,08 mln. | Nettowinst (verlies) 2024 * | -26 mln. -28,06 mln. | EV/omzet 2023 | 1,51 x |
Nettoliquiditeiten 2023 * | - 0 | Nettoliquiditeiten 2024 * | - 0 | EV/omzet 2024 * | 0,85 x |
K/w-verhouding 2023 |
-2,37
x | K/w-verhouding 2024 * |
-2,58
x | Werknemers | 255 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 97,37% |
Recentste transcriptie over MDxHealth SA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,30% | 45,97 mld. | |
+52,73% | 43,93 mld. | |
+7,15% | 42,34 mld. | |
-8,78% | 28,27 mld. | |
+18,68% | 27,18 mld. | |
-21,92% | 19,44 mld. | |
+14,62% | 13,83 mld. | |
+31,85% | 12,4 mld. | |
+4,47% | 11,45 mld. |